What is Integra Lifesciences Holdings Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. Integra Lifesciences Holdings's pretax income for the
three
months ended in Sep. 2024 was $-20 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-12 Mil.
Integra Lifesciences Holdings's pretax margin was -5.35%.
During the past 13 years, Integra Lifesciences Holdings's highest Pretax Margin was 13.92%. The lowest was -0.76%. And the median was 6.27%.
Integra Lifesciences Holdings Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Integra Lifesciences Holdings Pre-Tax Income Chart
Competitive Comparison of Integra Lifesciences Holdings's Pre-Tax Income
For the Medical Devices subindustry, Integra Lifesciences Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's Pre-Tax Income falls into.
Integra Lifesciences Holdings Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings (NAS:IART) Pre-Tax Income Explanation
Integra Lifesciences Holdings's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as
During the past 13 years, Integra Lifesciences Holdings's highest Pretax Margin was 13.92%. The lowest was -0.76%. And the median was 6.27%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Integra Lifesciences Holdings Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IART has been successfully added to your 